Bristol-Myers Squibb Company Dividends
The next dividend date for Bristol-Myers Squibb Company has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Bristol-Myers Squibb Company (BMY)
| 07/02/2026 | 06/17/2026 | 07/02/2026 | 08/03/2026 | $0.63 |
| 04/02/2026 | 03/02/2026 | 04/02/2026 | 05/01/2026 | $0.63 |
| 01/02/2026 | 12/10/2025 | 01/02/2026 | 02/02/2026 | $0.63 |
| 10/03/2025 | 09/17/2025 | 10/03/2025 | 11/03/2025 | $0.62 |
| 07/03/2025 | 06/17/2025 | 07/03/2025 | 08/01/2025 | $0.62 |
| 04/04/2025 | 03/03/2025 | 04/04/2025 | 05/01/2025 | $0.62 |
| 01/03/2025 | 12/11/2024 | 01/03/2025 | 02/03/2025 | $0.62 |
| 10/04/2024 | 09/10/2024 | 10/04/2024 | 11/01/2024 | $0.60 |
| 07/05/2024 | 06/18/2024 | 07/05/2024 | 08/01/2024 | $0.60 |
| 04/04/2024 | 03/01/2024 | 04/05/2024 | 05/01/2024 | $0.60 |
More About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Opdualag to treat unresectable or metastatic melanoma; and Camzyos for the treatment of symptomatic obstructive HCM. The company also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu to treat moderate-to-severe plaque psoriasis; Krazati for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for the reduction of risk of stroke/systemic embolism and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug for multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane to treat breast cancer. Further, the company provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC, as well as NSCLC and pancreatic cancer. It sells its products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies. The company has a strategic collaboration with Arcus Biosciences, Inc. to develop a treatment regimen that delivers tumor control in kidney cancer. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.
Owning Bristol-Myers Squibb Company Stock on the Dividend Date
If you own Bristol-Myers Squibb Company stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Bristol-Myers Squibb Company stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Bristol-Myers Squibb Company stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Bristol-Myers Squibb Company stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Bristol-Myers Squibb Company dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Owning Bristol-Myers Squibb Company Options on the Dividend Date
Unlike the stock price, which will normally have an abrupt decrease by the amount of the dividend on the ex-dividend date, option prices typically do not reflect the same phenomenon.
The reason is that in the time leading up to the ex-dividend date, that projected drop in Bristol-Myers Squibb Company stock price from the dividend is already baked into Bristol-Myers Squibb Company option prices.
That means the prices of call options that overlap the Bristol-Myers Squibb Company ex-dividend date typically go down in the period leading up to the ex-dividend date.
The prices of put options that overlap the Bristol-Myers Squibb Company ex-dividend date typically go up in the period leading up to the ex-dividend date.
Owners of Bristol-Myers Squibb Company call options do not receive the dividend, even if they own the options on the ex-dividend date. Owners of Bristol-Myers Squibb Company put options are not responsible to pay the dividend, even if they own the options on the ex-dividend date.
Learning More Bristol-Myers Squibb Company Dividends
You can contact us any time if you would like to ask questions about Bristol-Myers Squibb Company dividends or anything else related to the stock market.